Zelrix Sumatriptan Anti-Migraine Patch Going to FDA for Review

MedGadget - NuPathe Inc. out of Conshohocken, Pennsylvania has announced that US FDA has accepted for filing the company's New Drug Application (NDA) for Zelrix electronic transdermal patch, a pharmaceutical designed to treat migraines.

Read Full Story >>
The story is too old to be commented.